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A 29-year-old woman had undergone gastrocystoplasty with Mitrofanoff appendicovesicostomy for
urethral trauma at 9 years of age. Since then, she was being followed up for performing clean intermittent
self-catheterization at regular intervals. Twenty years after the surgery, she presented with gross hematuria.
Ultrasonographic ﬁndings revealed bilateral hydronephrosis. Cystoscopy and computed tomography (CT)
revealed invasive bladder cancer with pelvic lymph node metastases. A biopsy conﬁrmed the diagnosis of
adenocarcinoma with signet ring cell carcinoma. Subsequently, neo-adjuvant combination chemotherapy
with TS-1 and cisplatin (CDDP) was initiated, which was followed by open radical cystectomy with extended
pelvic lymphadenectomy. The tumor was found to inﬁltrate from the anastomotic site into the entire native
bladder and histopathological diagnosis was muscle invasive adenocarcinoma with neuroendocrine
differentiation and lymph node metastasis (ypT3bN2). TS-1 was continued as adjuvant chemotherapy and
the patient did not have any evidence of recurrence for 12 months postoperatively.
(Hinyokika Kiyo 62 : 33-37, 2016)








患 者 : 29歳，女性





















現 症 : 身長 160 cm，体重 79.5 kg，BMI 31．上下
腹部正中切開痕あり．腹部所見を含め理学的には明ら
かな異常を認めなかった．
血液生化学検査では Hb 12.5 g/dl，Cre 1.48 mg/dl
と軽度の貧血，腎機能低下を認めた．腫瘍マーカーは
CEA 8. 7 ng/ml（＜ 5. 0 ng/ml），CA19-9 44. 7 U/ml
（＜37.0 U/ml），NSE 14.77 ng/ml（＜12.0 ng/ml）が
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Fig. 1. MRI showed the invasive bladder tumor and
pelvic lymph node swellings.
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Fig. 2. Adenocarcinoma with signet ring cell carci-
noma of biopsy specimens.
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Fig. 3. The tumor inﬁltrated from the anastomotic







た，脾臓腹側に 3 cm 大の楕円形腫瘤影を認めたが，
FDG-PET での集積は弱く，転移は否定的であった．
その他，明らかな遠隔転移は認めなかった．





た．両側腎瘻造設術後に腎機能は Cre 0.71 mg/dl ま
で改善を認めた．化学療法は，リンパ節転移を伴う進
行胃癌に準じて，2014年 4月より TS-1，シスプラチ
ンの投与を開始した．TS-1（120 mg/day）を 3 週投
与 2 週休薬，シスプラチン（60 mg/m2）を 8 日目に
投与する 5週周期のレジメンで計 2コース投与した．
各コース終了時点の CT で，膀胱腫瘍および腫大リン
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Fig. 4. a) TS-1 had a therapeutic effect on the component of adenocarcinoma (H & E
staining, ×40). b) Adenocarcinoma with neuroendocrine differentiation arising
in native bladder (H & E staining, ×200). c) The tumor cells are strongly
positive for synaptophysin, and d) CD56.
Table 1. Clinical features of the patients of malignancy after augumentation gastrocystoplasty







組織型 発生部位 臨床病期 治療 転帰









瘤 14 27，男 腺癌 胃部膀胱 T2N0M0 手術
12カ月 癌な
し生存












二分脊椎 14 20，男 尿路上皮癌 吻合部 T4N2M1 化学療法i) 1カ月 癌死
6 二分脊椎 11 24，男 腺癌 吻合部 T2N0M0 手術 36カ月 癌なし生存
7 二分脊椎 14 32，男 腺癌 吻合部 T1N0M0 手術 14カ月 癌なし生存
8 二分脊椎 12 34，男 腺癌（印環細胞) 全体 T3N0M0
手術，放射















，男 腺癌 吻合部∼固有膀胱 T3N1M0 手術 記載なし
12 2014 Lin19)
神経節細
胞腫 16 24，女 腺癌 固有膀胱 TXN0M0 手術 記載なし







i) Carboplatin＋Paclitaxel (PTX), ii) 5-FU＋Leucovorin, iii) PTX＋Cisplatin (CDDP)＋5-FU, Oxaliplatin＋Epirubicin＋Capecitabin,
Gemcitabin＋CDDP, iv) TS-1＋CDDP.
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